新型冠状病毒2型（SARS-CoV-2）大流行改变了医疗资源的分配，导致许多非必要治疗和手术被暂停，给医务人员带来了挑战。本研究的目的是评估妇科肿瘤学护理的临床协议是否因大流行而发生修改，并评估外科医生对妇科癌症管理的认知。通过电子邮件发送匿名自愿调查表，收集在西班牙妇科肿瘤学领域的医疗专业人员的数据。共有75名妇科肿瘤学家完成了在线调查。其中，93.2%（69人）报告在公立医院工作，62.5%（45人）在三级医院工作。有97.3%（71人）的医生与治疗SARS-CoV-2感染患者的医院有所关联。85.1%（63人）的受访者对SARS-CoV-2大流行表示担忧，52.1%（38人）表示大流行对癌症患者的诊断和治疗质量产生了影响。97.3%（71人）的医生在手术前始终进行SARS-CoV-2鼻咽拭子PCR（聚合酶链反应）测试，94.4%（68人）认为这是一种分流的最佳实践。87.5%（63人）报告在大流行期间未改变手术方式。62.5%（45人）在获得用于SARS-CoV-2的特殊个人防护装备方面遇到了限制。70.4%（50人）报告由于大流行对妇科癌症患者的随访产生了影响。对我们调查的西班牙妇科肿瘤学家中的大多数人来说，SARS-CoV-2大流行影响了他们的临床实践。实施的主要措施包括增加远程医疗，在门诊中限制高风险或有症状的患者的访问，并在手术前进行SARS-CoV-2筛查。据报道，SARS-CoV-2大流行期间对卵巢、子宫内膜或宫颈癌的手术方法或治疗管理没有发生重大变化。© 2023. BioMed Central Ltd.，Springer Nature的一部分。

The SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) pandemic changed the distribution of healthcare resources, leading in many cases to the suspension of all non-essential treatments and procedures and representing a challenge for medical professionals. The objective of this study was to evaluate whether clinical protocols in gynecologic oncology care were modified as a result of the pandemic and to assess surgeons' perceptions regarding the management of gynecologic cancers".Data were collected through an anonymous and voluntary survey sent via email to healthcare professionals in the field of gynecologic oncology in Spain.A total of 75 gynecologic oncologists completed the online survey. Of these, 93.2% (69) reported working in public hospitals and 62.5% (45) in tertiary care hospitals. 97.3% (71) were affiliated with hospitals treating patients infected with SARS-CoV-2. 85.1% (63) of the respondents expressed concern about the SARS-CoV-2 pandemic and 52.1% (38) indicated that the pandemic impacted the diagnostic and therapeutic quality of care for oncology patients. SARS-CoV-2 nasopharyngeal swab PCR (Polymerase Chain Reaction) testing was always performed before surgical interventions by 97.3% (71), being considered a best practice in triage by 94.4% (68). 87.5% (63) reported no change in the type of surgical approach during the pandemic. 62.5% (45) experienced limitations in accessing special personal protective equipment for SARS-CoV-2. An impact on the follow-up of patients with gynecologic cancers due to the pandemic was reported by 70.4% (50).Most of the Spanish gynecologic oncologists who responded to our survey reported that the SARS-CoV-2 pandemic had affected their clinical practice. The primary measures implemented were an increase in telemedicine, restricting outpatient visits to high-risk or symptomatic patients and the use of SARS-CoV-2 screening prior to surgery. No major changes in the surgical approach or management of the treatment of ovarian, endometrial or cervical cancer during the pandemic were reported.© 2023. BioMed Central Ltd., part of Springer Nature.